There is no fee for this educational activity.

---

Faculty:

Michael H. Criqui, MD, MPH
Professor and Chief,
Division of Preventive Medicine
Dept. of Family and Preventive Medicine
Professor, Dept. of Medicine
University of California, San Diego
La Jolla, CA

William A. Marston, MD
Associate Professor of Surgery
Division of Vascular Surgery
UNC Hospitals
Chapel Hill, NC

Vickie R. Driver, MS, DPM, FACFAS
Director, Clinical Research
Foot Care, Endovascular and Vascular
Services Department of Surgery
Boston Medical Center and
Boston University School of Medicine
Boston, MA

Douglas W. Losordo, MD, Activity Chair
Director, Feinberg Cardiovascular
Research Institute
Eileen M. Foell Professor of Heart Research
Northwestern University Feinberg
School of Medicine
Director, Program in Cardiovascular
Regenerative Medicine
Northwestern Memorial Hospital
Chicago, IL

---

Topics

MICHAEL H. CRIQUI, MD, MPH
The Large Burden of PAD in the United States

WILLIAM A. MARSTON, MD
Managing Vascular Challenges in the Critical Limb Ischemia Patient

VICKIE R. DRIVER, MS, DPM, FACFAS
Arterial and Mixed Etiology Wounds in CLI Patients: What is New in Diagnosis and Treatment

DOUGLAS W. LOSORDO, MD, ACTIVITY CHAIR
Adult Stem Cell Therapy for CLI: Changing the Paradigm for End-Stage Disease

---

Target Audience:
This activity has been developed for interventional cardiologists, clinical cardiologists, vascular surgeons, interventional radiologists, wound care specialists, podiatrists, endocrinologists, vascular allied healthcare professionals, diabetes educators, and primary care physicians.

---

Learning Objectives:

Upon completion of this educational activity, participants should be able to:

• define peripheral arterial disease (PAD) and critical limb ischemia (CLI) • identify the burden of PAD in the United States by gender and ethnicity • understand the underlying diseases and lifestyle choices that contribute to the large burden of PAD • identify the consequences associated with PAD and CLI • describe the changing paradigm of surgery to endovascular interventions • list endovascular options in the CLI patient • identify the impact of comorbid conditions on treatment of these patients • perform a differential diagnosis for nonhealing wounds • review the standard of care for these wounds and the inclusion of advanced therapies • utilize timely and appropriate referral and multidisciplinary care for patients • describe clinical trials underway with gene therapies and growth factors • discuss the role of angiogenesis in PAD and CLI • identify autologous cell types and sources with potential for treatment of CLI • discuss clinical trials using adult stem cells for CLI.

---

Accreditation:

MD/DO:This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Podiatrists: NACCME is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine. This program is approved for 1 continuing education contact hour.

Nurses: ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour (Provider Number 110-3-E-06). Provider approved by the California Board of Registered Nursing, Provider Number 13255, for 1 contact hour..

Technologists: Approved for 1 Category A ARRT continuing education credit.

---

Faculty/Planners/Reviewer Disclosures:
All those with control over the content of continuing education programs sponsored by NACCME are expected to disclose whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). It is not assumed that these relationships will have an adverse impact on presentations; they are simply noted here to fully inform participants.

Planner & Faculty
Dr. Losordo has disclosed that he is a consultant to AcellRx, Anormed, Biocardia, CellCyte, Genzyme, Baxter, Cordis, Inseptioun, NeoStem, Pluristem, REMED1, and WMR Biomedical.

Faculty:
Dr. Driver has disclosed that she has received grant/research support; she is a member of the speakers’ bureau and a scientific advisor to Baxter and Sanofi-Aventis.

Dr. Marston has disclosed that he is a consultant to Baxter.

Dr. Criqui has disclosed that he has no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of his presentation.

Reviewer:
Dr. Dieter has disclosed that he has no relevant financial relationships with any organization that could be perceived as a conflict of interest.

---

Commercial Supporter:

This activity is supported by an educational grant from Baxter Healthcare Corporation.

---

This activity is sponsored by the North American Center for Continuing Medical Education.

---